Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 30, 2016

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Cochlear Implant
Interventions
DEVICE

cochlear implantation

"Surgery is standardized in order to have the same procedure for all patients and to preserve a maximum of residual hearing:~* Corticosteroïds (1mg/kg solumedrol) at anesthetic induction ,~* mastoidectomy + posterieur tympanostomy ,~* insertion through round window,~* stop at the first resistance point"

Trial Locations (8)

Unknown

CHU Bordeaux Pellegrin, Bordeaux

CHRU Lille Hôpital Roger Salengro, Lille

CHU Lyon Hôpital Edouard Herriot, Lyon

APHM - Hôpital Nord Marseille, Marseille

CHRU de Nancy hôpital Central, Nancy

IUFC - CHU Nice, Nice

APHP Pitie salpetriere, Paris

CHU Rennes Pontchaillou, Rennes

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Oticon Medical

INDUSTRY

NCT02966379 - Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor | Biotech Hunter | Biotech Hunter